A Study of ASP2074 in Adults With Solid Tumors

Clinical trial NCT05646797 · TERMINATED

Trial details

NCT number: NCT05646797
Sponsor: Astellas Pharma Global Development, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2023-02-28
Primary completion: 2024-10-17
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.